A case of refractory cholestatic drug-induced liver injury caused by amoxicillin/clavulanate effectively treated with phenobarbital
Kanzo/Acta Hepatologica Japonica, ISSN: 1881-3593, Vol: 65, Issue: 9, Page: 433-439
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
A man in his 70s administered amoxicillin/clavulanate (AMPC/CVA) for 6 weeks for lung abscess treatment presented at our hospital with jaundice one week after treatment completion. Based on the DDW-J 2004 diagnostic criteria for drug-induced liver injury (DILI), the patient scored 6 points, raising suspicion of liver damage caused by AMPC/CVA. His jaundice worsened after initiation either of conservative therapy or PSL 30 mg and UDCA 300 mg after 1st liver biopsy. Although corticosteroid pulse therapy or taurine had no effect following 2nd liver biopsy, phenobarbital (PB) 120 mg/day exhibited outstanding effectiveness in reducing jaundice. We monitored the normal total bilirubin range after PB discontinuation. This case seems to be uncommon because of the characteristic course of cholestatic DILI due to AMPC/CVA and the remarkable effect of PB for refractory jaundice.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know